These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23290891)

  • 41. [Conjugate vaccines changed the epidemiology of infection].
    Ecker-Schlipf B
    Med Monatsschr Pharm; 2006 Aug; 29(8):307-8. PubMed ID: 16927601
    [No Abstract]   [Full Text] [Related]  

  • 42. Expected benefits of pneumococcal vaccination in Canadian infants and children < 5 years old.
    Can Commun Dis Rep; 2006 Mar; 32(5):45-54. PubMed ID: 16649291
    [No Abstract]   [Full Text] [Related]  

  • 43. The future of pneumococcal disease prevention.
    Rodgers GL; Klugman KP
    Vaccine; 2011 Sep; 29 Suppl 3():C43-8. PubMed ID: 21896352
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Update on the recommendations for the routine use of pneumococcal conjugate vaccine for infants. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2006 May; 32(ACS-4):1-6. PubMed ID: 16718922
    [No Abstract]   [Full Text] [Related]  

  • 45. [Pneumococcal vaccine in patients infected with the human immunodeficiency virus].
    Falcó Ferrer V; Len Abad O; Pahissa Berga A
    Rev Clin Esp; 2002 Jul; 202(7):395-8. PubMed ID: 12139825
    [No Abstract]   [Full Text] [Related]  

  • 46. Efficacy of pneumococcal polysaccharide vaccine.
    Scott P; Huss A; Stuck AE; Trotter C; Egger M
    CMAJ; 2009 May; 180(11):1134-5; author reply 1135. PubMed ID: 19468126
    [No Abstract]   [Full Text] [Related]  

  • 47. Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe.
    Rose M; Zielen S
    Expert Rev Vaccines; 2009 Oct; 8(10):1351-64. PubMed ID: 19803758
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the indirect effects of a pneumococcal vaccine in a community-randomized study.
    Moulton LH; O'Brien KL; Reid R; Weatherholtz R; Santosham M; Siber GR
    J Biopharm Stat; 2006; 16(4):453-62. PubMed ID: 16892907
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety and effectiveness against respiratory tract infections for pneumococcal conjugate vaccine co-administered with routine vaccine combinations.
    Adam D; Fehnle K
    Vaccine; 2008 Nov; 26(47):5944-51. PubMed ID: 18801402
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunization coverage against invasive pneumococcal disease among children in the Capital Health Region of Alberta.
    Can Commun Dis Rep; 2005 Mar; 31(6):65-8. PubMed ID: 15875323
    [No Abstract]   [Full Text] [Related]  

  • 51. Declining invasive pneumococcal disease in the U.S. elderly.
    McBean AM; Park YT; Caldwell D; Yu X
    Vaccine; 2005 Dec; 23(48-49):5641-5. PubMed ID: 16111788
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pneumococcal vaccination of adults: polysaccharide or conjugate.
    Med Lett Drugs Ther; 2009 Jun; 51(1314):47-8. PubMed ID: 19528887
    [No Abstract]   [Full Text] [Related]  

  • 53. Infant immunisation with a pneumococcal conjugate vaccine: from the age of two months, for all infants.
    Prescrire Int; 2006 Dec; 15(86):227-33. PubMed ID: 17167934
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical experience with pneumococcal conjugate vaccines in infants and children.
    Jackson CR
    J Am Osteopath Assoc; 2002 Aug; 102(8):431-6. PubMed ID: 12201547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pneumococcal empyema: impact of immunization.
    Jhaveri R
    Pediatr Infect Dis J; 2006 Sep; 25(9):854; author reply 854. PubMed ID: 16940853
    [No Abstract]   [Full Text] [Related]  

  • 56. Prevention of pneumococcal disease among adults.
    Maxim RB
    Med Health R I; 2001 May; 84(5):174-5. PubMed ID: 11392959
    [No Abstract]   [Full Text] [Related]  

  • 57. Pneumococcal polysaccharide vaccines.
    Werre JM; de Haan LD
    Neth J Med; 2005 Apr; 63(4):152. PubMed ID: 15869046
    [No Abstract]   [Full Text] [Related]  

  • 58. Respiratory viral and pneumococcal coinfection of the respiratory tract: implications of pneumococcal vaccination.
    Moore DP; Dagan R; Madhi SA
    Expert Rev Respir Med; 2012 Aug; 6(4):451-65. PubMed ID: 22971069
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pneumococcal vaccine: to vaccinate or to revaccinate--that is the question.
    Uiterwyk SH
    Med Health R I; 2004 Mar; 87(3):68-71. PubMed ID: 15085683
    [No Abstract]   [Full Text] [Related]  

  • 60. [Pneumococcal vaccines: different types and their use in practice].
    Van Steenkiste M
    J Pharm Belg; 2013 Mar; (1):4-11. PubMed ID: 23638606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.